185 related articles for article (PubMed ID: 33318034)
1. A Call to Action: Dismantling Racial Injustices in Preclinical Research and Clinical Care of Black Patients Living with Small Cell Lung Cancer.
Thomas PL; Madubata CJ; Aldrich MC; Lee MM; Owonikoko TK; Minna JD; Rudin CM; Sage J; Lovly CM
Cancer Discov; 2021 Feb; 11(2):240-244. PubMed ID: 33318034
[TBL] [Abstract][Full Text] [Related]
2. Association of Race, Socioeconomic Factors, and Treatment Characteristics With Overall Survival in Patients With Limited-Stage Small Cell Lung Cancer.
Zhou K; Shi H; Chen R; Cochuyt JJ; Hodge DO; Manochakian R; Zhao Y; Ailawadhi S; Lou Y
JAMA Netw Open; 2021 Jan; 4(1):e2032276. PubMed ID: 33433596
[TBL] [Abstract][Full Text] [Related]
3. Small cell lung cancer: will recent progress lead to improved outcomes?
Pietanza MC; Byers LA; Minna JD; Rudin CM
Clin Cancer Res; 2015 May; 21(10):2244-55. PubMed ID: 25979931
[TBL] [Abstract][Full Text] [Related]
4. Novel targeted strategies to overcome resistance in small-cell lung cancer: focus on PARP inhibitors and rovalpituzumab tesirine.
Van Den Borg R; Leonetti A; Tiseo M; Giovannetti E; Peters GJ
Expert Rev Anticancer Ther; 2019 Jun; 19(6):461-471. PubMed ID: 31148500
[No Abstract] [Full Text] [Related]
5. [Other thoracic cancers. Small-cell lung cancer: an update].
Vermaelen K; van Meerbeeck JP
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S173-82. PubMed ID: 18971843
[TBL] [Abstract][Full Text] [Related]
6. Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges.
Leonetti A; Facchinetti F; Minari R; Cortellini A; Rolfo CD; Giovannetti E; Tiseo M
Cell Oncol (Dordr); 2019 Jun; 42(3):261-273. PubMed ID: 30968324
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
Owonikoko TK; Zhang G; Kim HS; Stinson RM; Bechara R; Zhang C; Chen Z; Saba NF; Pakkala S; Pillai R; Deng X; Sun SY; Rossi MR; Sica GL; Ramalingam SS; Khuri FR
J Transl Med; 2016 May; 14(1):111. PubMed ID: 27142472
[TBL] [Abstract][Full Text] [Related]
8. Lurbinectedin for the treatment of small cell lung cancer.
Li L; Zou C; Dong S; Wu ZX; Ashby CR; Chen ZS; Qiu C
Drugs Today (Barc); 2021 Jun; 57(6):377-385. PubMed ID: 34151904
[TBL] [Abstract][Full Text] [Related]
9. New targeted therapies and small-cell lung cancer.
Rossi A; Maione P; Palazzolo G; Sacco PC; Ferrara ML; Falanga M; Gridelli C
Clin Lung Cancer; 2008 Sep; 9(5):271-9. PubMed ID: 18824449
[TBL] [Abstract][Full Text] [Related]
10. Ganitumab for the treatment of small-cell lung cancer.
Martínez P; Sales Fidalgo PA; Felip E
Expert Opin Investig Drugs; 2014 Oct; 23(10):1423-32. PubMed ID: 25189625
[TBL] [Abstract][Full Text] [Related]
11. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
Ragavan M; Das M
Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model].
Zhu Y; Huang W; Wu Y; Jia L; Li Y; Chen R; Guo L; Chen Q
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):6-14. PubMed ID: 30674387
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies for small cell lung cancer: Where do we stand?
Arcaro A
Crit Rev Oncol Hematol; 2015 Aug; 95(2):154-64. PubMed ID: 25800975
[TBL] [Abstract][Full Text] [Related]
14. Personalized Therapy of Small Cell Lung Cancer.
Schneider BJ; Kalemkerian GP
Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
[TBL] [Abstract][Full Text] [Related]
15. Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment.
Zhu Y; Cui Y; Zheng X; Zhao Y; Sun G
Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166557. PubMed ID: 36162624
[TBL] [Abstract][Full Text] [Related]
16. Survival of Black and White Patients With Stage IV Small Cell Lung Cancer.
Shi H; Zhou K; Cochuyt J; Hodge D; Qin H; Manochakian R; Zhao Y; Ailawadhi S; Adjei AA; Lou Y
Front Oncol; 2021; 11():773958. PubMed ID: 34956892
[TBL] [Abstract][Full Text] [Related]
17. Accurate treatment of small cell lung cancer: Current progress, new challenges and expectations.
Zhang C; Wang H
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188798. PubMed ID: 36096336
[TBL] [Abstract][Full Text] [Related]
18. NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model.
Liu Y; Li Y; Liu S; Adeegbe DO; Christensen CL; Quinn MM; Dries R; Han S; Buczkowski K; Wang X; Chen T; Gao P; Zhang H; Li F; Hammerman PS; Bradner JE; Quayle SN; Wong KK
Cancer Res; 2018 Jul; 78(13):3709-3717. PubMed ID: 29760044
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.
Némati F; Daniel C; Arvelo F; Legrier ME; Froget B; Livartowski A; Assayag F; Bourgeois Y; Poupon MF; Decaudin D
Anticancer Drugs; 2010 Jan; 21(1):25-32. PubMed ID: 19823076
[TBL] [Abstract][Full Text] [Related]
20. Association of Smoking With Patient Characteristics and Outcomes in Small Cell Lung Carcinoma, 2011-2018.
Tseng JS; Chiang CJ; Chen KC; Zheng ZR; Yang TY; Lee WC; Hsu KH; Huang YH; Liu TW; Hsia JY; Chang GC
JAMA Netw Open; 2022 Mar; 5(3):e224830. PubMed ID: 35353165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
